Table 1.
mRNA | Control (n = 7) | CH-C (n = 34) | P value |
CH-C |
P value | |
Women (n = 16) | Men (n = 18) | |||||
class 1 (P1) | 0.19 ± 0.21 | 0.45 ± 0.45 | P = 0.025 | 0.63 ± 0.59 | 0.28 ± 0.17 | P = 0.003 |
class 2 (P2) | 0.08 ± 0.07 | 0.15 ± 0.17 | P = 0.164 | 0.20 ± 0.15 | 0.11 ± 0.18 | P = 0.006 |
IGF-1A | 1.30 ± 1.31 | 5.28 ± 9.94 | P = 0.009 | 7.88 ± 13.83 | 2.97 ± 3.32 | P = 0.027 |
IGF-1B | 0.18 ± 0.18 | 0.28 ± 0.40 | P = 0.486 | 0.35 ± 0.45 | 0.22 ± 0.35 | P = 0.042 |
IGF-1C | 0.04 ± 0.05 | 0.21 ± 0.57 | P = 0.031 | 0.35 ± 0.82 | 0.08 ± 0.06 | P = 0.046 |
Total IGF-1 | 1.52 ± 1.52 | 5.77 ± 10.85 | P = 0.014 | 8.58 ± 15.09 | 3.26 ± 3.70 | P = 0.027 |
IGF-1R | 0.26 ± 0.18 | 0.14 ± 0.04 | P = 0.016 | 0.14 ± 0.05 | 0.14 ± 0.04 | P = 0.295 |
IGF-1: Insulin-like growth factor 1; CH-C: Chronic hepatitis C.